Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immuron Ltd ADR (IMRN)

Immuron Ltd ADR (IMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immuron Ltd ADR 62 LYGON STREET LEVEL 3 CARLTON C3 3053 AUS

www.immuron.com.au P: 039-824-5254 F: +61 398227735

Description:

Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale, Australia.

Key Statistics

Overview:

Market Capitalization, $K 14,364
Enterprise Value, $K 2,814
Shares Outstanding, K 5,700
Annual Sales, $ 1,210 K
Annual Net Income, $ -2,550 K
EBIT, $ 0 K
EBITDA, $ -2,370 K
60-Month Beta 1.48
% of Insider Shareholders 7.01%
% of Institutional Shareholders 0.12%
Float, K 5,300
% Float 92.99%
Short Volume Ratio 0.42

Growth:

1-Year Return 35.03%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -15.38%
5-Year Earnings Growth 36.62%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/30/23
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IMRN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -210.74%
Debt/Equity 0.00
Price/Sales 11.92
Price/Cash Flow N/A
Price/Book 1.27
Book Value/Share 2.00
Interest Coverage -254.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar